Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya-Reference-Cited by-同舟云学术

Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya

Published:2022-03 Issue: Volume:Volume 15 Page:2415-2425
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Shah Reena^ORCID,Shah Jasmit,Gohil Jaimini,Revathi Gunturu,Surani Salim

Publisher

Informa UK Limited

Subject

General Medicine

Reference38 articles.

1. Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19

2. Corona Virus Update Worldometer: John Hopkins; 2021. Available from: https://www.worldometers.info/coronavirus/. Accessed February 22, 2022.

3. Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial

4. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa;Clinical Immunology;2024-09

2. The Frequency and the character of bacterial infection in patients with COVID-19;South Russian Journal of Therapeutic Practice;2023-03-28

3. Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report;IDCases;2023

4. Efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis;Inflammopharmacology;2022-11-29

5. Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya;2022-10-10